These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 20012621)
21. Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients. Francès C; Papo T; Wechsler B; Laporte JL; Biousse V; Piette JC Medicine (Baltimore); 1999 Jul; 78(4):209-19. PubMed ID: 10424203 [TBL] [Abstract][Full Text] [Related]
22. A rarely seen syndrome in rehabilitation of hemiplegia: antiphospholipid antibody-negative Sneddon's syndrome. Akbal A; Kurtaran A; Selçuk B; Ersöz M; Akyüz M Rheumatol Int; 2010 Sep; 30(11):1489-91. PubMed ID: 19697034 [TBL] [Abstract][Full Text] [Related]
23. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study. Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381 [TBL] [Abstract][Full Text] [Related]
25. Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke? Camargo EW; Freire PV; Silva CA; dos Santos NR; da Mota LM; Pereira RM; de Carvalho JF Rheumatol Int; 2012 Jun; 32(6):1721-5. PubMed ID: 21437687 [TBL] [Abstract][Full Text] [Related]
26. Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism. Gary T; Belaj K; Bruckenberger R; Hackl G; Hafner F; Froehlich H; Zebisch A; Pilger E; Brodmann M Obesity (Silver Spring); 2013 Sep; 21(9):E463-6. PubMed ID: 23671009 [TBL] [Abstract][Full Text] [Related]
27. Hospital based prospective longitudinal clinical and immunologic study of 179 patients of primary anti-phospholipid syndrome. Singh NK; Behera DR; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Singh U; Pandey LK; Matah M Int J Rheum Dis; 2013 Oct; 16(5):547-55. PubMed ID: 24164842 [TBL] [Abstract][Full Text] [Related]
28. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production? de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747 [TBL] [Abstract][Full Text] [Related]
29. Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome. Gantcheva M; Tsankov N J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):157-60. PubMed ID: 10343946 [TBL] [Abstract][Full Text] [Related]
30. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome]. Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190 [TBL] [Abstract][Full Text] [Related]
31. Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Sinico RA; Cavazzana I; Nuzzo M; Vianelli M; Napodano P; Scaini P; Tincani A Clin J Am Soc Nephrol; 2010 Jul; 5(7):1211-7. PubMed ID: 20430943 [TBL] [Abstract][Full Text] [Related]
32. The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome. da Silva Saraiva S; de Moraes Mazetto B; Quinteiro Tobaldine L; Pereira Colella M; Vinícius De Paula E; Annichinno-Bizzachi J; Andrade Orsi F Am J Hematol; 2017 Nov; 92(11):1163-1169. PubMed ID: 28762539 [TBL] [Abstract][Full Text] [Related]
33. The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study. Duarte-García A; Pham MM; Crowson CS; Amin S; Moder KG; Pruthi RK; Warrington KJ; Matteson EL Arthritis Rheumatol; 2019 Sep; 71(9):1545-1552. PubMed ID: 30957430 [TBL] [Abstract][Full Text] [Related]
34. Protein Z deficiency in antiphospholipid-negative Sneddon's syndrome. Ayoub N; Esposito G; Barete S; Soria C; Piette JC; Francès C Stroke; 2004 Jun; 35(6):1329-32. PubMed ID: 15105516 [TBL] [Abstract][Full Text] [Related]
35. The family history of patients with primary or secondary antiphospholipid syndrome (APS). Weber M; Hayem G; DeBandt M; Palazzo E; Roux S; Kahn MF; Meyer O Lupus; 2000; 9(4):258-63. PubMed ID: 10866096 [TBL] [Abstract][Full Text] [Related]
36. Clinical and neuroradiological aspects of Sneddon's syndrome and primary antiphospholipid antibody syndrome. A follow-up study. Fetoni V; Grisoli M; Salmaggi A; Carriero R; Girotti F Neurol Sci; 2000 Jun; 21(3):157-64. PubMed ID: 11076004 [TBL] [Abstract][Full Text] [Related]
37. [Aspirin and antiphospholipid syndrome]. Hachulla E; Piette AM; Hatron PY; Blétry O Rev Med Interne; 2000 Mar; 21 Suppl 1():83s-88s. PubMed ID: 10763209 [TBL] [Abstract][Full Text] [Related]
38. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome. Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146 [TBL] [Abstract][Full Text] [Related]
39. Antiphospholipid-mediated thrombosis: interplay between type of antibodies and localisation of lung, and cardiovascular incidences in primary antiphospholipid syndrome. Stojanovich L; Djokovic A; Kontic M Clin Exp Rheumatol; 2015; 33(4):531-6. PubMed ID: 26088955 [TBL] [Abstract][Full Text] [Related]
40. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I; Levi Y; Godard G; Shoenfeld Y Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]